Skip to main content
. 2022 Feb;33(2):401–419. doi: 10.1681/ASN.2021050643

Table 3b.

Time to treatment failure: During the treatment period

Group No. of Patients No. of Patients with Treatment Failure No. of Patients Censored Median (95% CI) (days) Hazard Ratio (95% CI)
MMF 39 6 33 not reached 0.202 (0.08 to 0.50)
Placebo 39 21 18 493.0 (360.0 to not reached)